Genetic Susceptibility of Diabetic Retinopathy

Overview

Journal Curr Diab Rep

Publisher Current Science

Specialty Endocrinology

Date 2008 Jul 18

PMID 18631436

Citations 10

Authors

Shrena Patel

Haoyu Chen

Nicholas H Tinkham

Kang Zhang

Affiliations

Soon will be listed here.

Abstract

Diabetes continues to be a major source of -morbidity and mortality among working-age adults nationally and internationally. The microvascular complications of diabetes, including diabetic retinopathy, account for a major proportion of disease-associated morbidity and likely contribute to macrovascular complications. Although glycemic control contributes to -susceptibility for diabetic complications, some people with strict control develop these complications, whereas -others with poor control remain complication free. This suggests a genetic contribution to disease development. Although many genes and proteins of vascular growth have been studied in association with diabetic retinopathy, no definitive major predisposing genes or functional consequences of genetic variants have been identified for microvascular complications of the disease. In this article, we review the studies done on candidate genes.

Citing Articles

Assessment of MIR200B Polymorphisms Association with Sight-Threatening Diabetic Retinopathy.

Zal N, Safi S, Ahmadieh H, Fekri S, Najafi S, Forouhari A J Curr Ophthalmol. 2024; 35(4):355-361.

PMID: 39281402 PMC: 11392297. DOI: 10.4103/joco.joco_287_22.

Nanomedicine and drug delivery to the retina: current status and implications for gene therapy.

Tawfik M, Chen F, Goldberg J, Sabel B Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(12):1477-1507.

PMID: 36107200 PMC: 9630211. DOI: 10.1007/s00210-022-02287-3.

Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy.

More S, Kim I, Choi D Molecules. 2017; 22(1).

PMID: 28054988 PMC: 6155640. DOI: 10.3390/molecules22010076.

The role of NOS2A -954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management.

Porojan M, Catana A, Popp R, Dumitrascu D, Bala C Ther Clin Risk Manag. 2015; 11:1743-8.

PMID: 26664124 PMC: 4669928. DOI: 10.2147/TCRM.S93172.

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Lee R, Wong T, Sabanayagam C Eye Vis (Lond). 2015; 2:17.

PMID: 26605370 PMC: 4657234. DOI: 10.1186/s40662-015-0026-2.

References

Harris M, Klein R, Cowie C, Rowland M . Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care. 1998; 21(8):1230-5. DOI: 10.2337/diacare.21.8.1230. View

Garcia C, Wilund K, Arca M, Zuliani G, Fellin R, Maioli M . Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science. 2001; 292(5520):1394-8. DOI: 10.1126/science.1060458. View

Gardiner T, Anderson H, Stitt A . Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J Pathol. 2003; 201(2):328-33. DOI: 10.1002/path.1429. View

Barile G, Pachydaki S, Tari S, Lee S, Donmoyer C, Ma W . The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2005; 46(8):2916-24. DOI: 10.1167/iovs.04-1409. View

Clarke M, Dodson P . PKC inhibition and diabetic microvascular complications. Best Pract Res Clin Endocrinol Metab. 2007; 21(4):573-86. DOI: 10.1016/j.beem.2007.09.007. View

. A haplotype map of the human genome. Nature. 2005; 437(7063):1299-320. PMC: 1880871. DOI: 10.1038/nature04226. View

Saxena R, Voight B, Lyssenko V, Burtt N, de Bakker P, Chen H . Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316(5829):1331-6. DOI: 10.1126/science.1142358. View

Pritchard J . Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet. 2001; 69(1):124-37. PMC: 1226027. DOI: 10.1086/321272. View

Grant S, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J . Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006; 38(3):320-3. DOI: 10.1038/ng1732. View

10.

Girach A, Vignati L . Diabetic microvascular complications--can the presence of one predict the development of another?. J Diabetes Complications. 2006; 20(4):228-37. DOI: 10.1016/j.jdiacomp.2006.03.001. View

11.

Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D . A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445(7130):881-5. DOI: 10.1038/nature05616. View

12.

Tong Z, Yang Z, Patel S, Chen H, Gibbs D, Yang X . Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A. 2008; 105(19):6998-7003. PMC: 2383970. DOI: 10.1073/pnas.0800454105. View

13.

Kao Y, Donaghue K, Chan A, Knight J, Silink M . An aldose reductase intragenic polymorphism associated with diabetic retinopathy. Diabetes Res Clin Pract. 2000; 46(2):155-60. DOI: 10.1016/s0168-8227(99)00087-x. View

14.

Klein R, Zeiss C, Chew E, Tsai J, Sackler R, Haynes C . Complement factor H polymorphism in age-related macular degeneration. Science. 2005; 308(5720):385-9. PMC: 1512523. DOI: 10.1126/science.1109557. View

15.

Ladomery M, Harper S, Bates D . Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm. Cancer Lett. 2006; 249(2):133-42. DOI: 10.1016/j.canlet.2006.08.015. View

16.

Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K . A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002; 51(5):1635-9. DOI: 10.2337/diabetes.51.5.1635. View

17.

Scott L, Mohlke K, Bonnycastle L, Willer C, Li Y, Duren W . A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316(5829):1341-5. PMC: 3214617. DOI: 10.1126/science.1142382. View

18.

Lip P, Chatterjee S, Caine G, Hope-Ross M, Gibson J, Blann A . Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol. 2004; 88(12):1543-6. PMC: 1772428. DOI: 10.1136/bjo.2004.048587. View

19.

Ceriello A . New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care. 2003; 26(5):1589-96. DOI: 10.2337/diacare.26.5.1589. View

20.

Trevisan R, Vedovato M, Mazzon C, Coracina A, Iori E, Tiengo A . Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients. Diabetes Care. 2002; 25(11):2026-31. DOI: 10.2337/diacare.25.11.2026. View